The Food and Drug Administration has granted regular approval to cabozantinib for treatment of patients with advanced renal cell carcinoma (RCC). The FDA previously approved cabozantinib in 2016 for treatment of patients with advanced RCC who have...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2CuI4cd
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Is it feasible to develop an artificial intelligence algorithm that can actually... Read more on AuntMinnieEurope.com Related Reading: ...
-
Posttraumatic radioulnar synostosis (RUS) is a rare event following forearm fractures. Consequences are disabling for patients who suffer fr...
-
Security. Let's face it. Software has holes. And hackers love to exploit them. New vulnerabilities appear almost daily. If you have soft...
-
Abstract Salivary gland tumors are rare, comprising less than 3% of all neoplasia of head and neck region. Pleomorphic adenoma is the most ...
-
Cone beam computerized tomography (CBCT) has been widely used in dental implanting. However, the local hospitals usually don’t have access t...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2urgQN9 via IFTTT
-
Abstract Objectives The aim of this prospective cohort study was to determine the effects of rapid maxillary expansion (RME) on the firs...
-
Abstract Patients with locally advanced rectal cancer (LARC) are at tremendous risk of metastatic diseases. To improve the prognoses of LA...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου